Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis.

Hanlong ZhuSi ZhaoRuonan JiaoHuishan WangRuiyi TangXiaochao WuFei WangXianxiu GeQuanpeng LiLin Miao

Published in: Cancer cell international (2020)

Up-regulated SNHG20 expression is ubiquitous in different kinds of cancers. Moreover, up-regulated SNHG20 expression is capable of serving as an innovative predictive factor of inferior clinical outcomes in cancer patients. Nevertheless, higher-quality multicenter studies are required to corroborate our results.

Keyphrases

poor prognosis
long non coding rna
endothelial cells
transcription factor
binding protein
double blind
young adults
childhood cancer